(1) Tight inexpensive management (2) Cash flow + since Oct 2007 (3) More cash in July -Oct 2008 than whole of financial 08 (4) Nearly 300 independent medical journals reporting on QFT. Mostly + (5) Marketing ...Peer to Peer and sponsoring conferences like Dubrovnik (6) New product ...QFT CMV ...transplant patient market (7) some patents expiring soon...2011(US) and 2009 (Canada) (8) Office in Japan and approval for QFT INTUBE sought (9) Lower A$ a future benefit (10) No Divs (11) No progress with Military ...that I can see
CST Price at posting:
$2.20 Sentiment: Hold Disclosure: Held
